Multidrug-Resistant Bacteria in Surgical Intensive Care Units: Antibiotic Susceptibility and β-Lactamase Characterization.
Daniela Bandić PavlovićMladen PospišilMarina NađVilena Vrbanović MijatovićJosefa LuxnerGernot E ZarfelAndrea J GrisoldDinko TonkovićMirela DobrićBranka BedenićPublished in: Pathogens (Basel, Switzerland) (2024)
Multidrug-resistant (MDR) bacteria of the utmost importance are extended-spectrum β-lactamase (ESBL) and carbapenemase-producing Enterobacterales (CRE), carbapenem-resistant Acinetobacter baumannii (CRAB), carbapenem-resistant Pseudomonas aeruginosa (CRPA), methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococcus spp. (VRE). In this study, an evaluation of MDR bacteria in surgical intensive care units in a tertiary referral hospital was conducted. The study aimed to characterize β-lactamases and other resistance traits of Gram-negative bacteria isolated in surgical intensive care units (ICUs). Disk diffusion and the broth dilution method were used for antibiotic susceptibility testing, whereas ESBL screening was performed through a double disk synergy test and an inhibitor-based test with clavulanic acid. A total of 119 MDR bacterial isolates were analysed. ESBL production was observed in half of the Proteus mirabilis , 90% of the Klebsiella pneumoniae and all of the Enterobacter cloacae and Escherichia coli isolates. OXA-48 carbapenemase, carried by the L plasmid, was detected in 34 K. pneumoniae and one E. coli and Enterobacter cloacae complex isolates, whereas NDM occurred sporadically and was identified in three K. pneumoniae isolates. OXA-48 positive isolates coharboured ESBLs belonging to the CTX-M family in all but one isolate. OXA-23 carbapenemase was confirmed in all A. baumannii isolates. The findings of this study provide valuable insight of resistance determinants of Enterobacterales and A. baumannii which will enhance surveillance and intervention strategies that are necessary to curb the ever-growing carbapenem resistance rates.
Keyphrases
- klebsiella pneumoniae
- multidrug resistant
- acinetobacter baumannii
- escherichia coli
- drug resistant
- gram negative
- methicillin resistant staphylococcus aureus
- intensive care unit
- pseudomonas aeruginosa
- genetic diversity
- staphylococcus aureus
- randomized controlled trial
- biofilm formation
- emergency department
- healthcare
- primary care
- public health
- liquid chromatography tandem mass spectrometry
- genome wide
- cystic fibrosis
- gene expression
- candida albicans
- acute respiratory distress syndrome